Intralesional vimblastine in oral Kaposi Sarcoma

Authors

  • Valdomiro Francisco Barbosa-Filho Instituto de Infectologia Emílio Ribas, Saúde bucal - São Paulo - São Paulo - Brasil
  • Sergio Luis Funari Instituto de Infectologia Emílio Ribas, Saúde bucal - São Paulo - São Paulo - Brasil

DOI:

https://doi.org/10.5935/2764-734X.e202201008

Keywords:

Sarcoma, Kaposi, Injectionsf, Intralesional, Herpesvirus 8, Human, HIV Infections, Vinblastine

Abstract

Kaposi’s sarcoma (KS) is a multicentric vascular neoplasm characterized by reddish or violet lesions on the skin, mucous membranes, and other sites. Associated with type 8 herpesvirus, it is more prevalent in men who have sex with men (MSM) and the mouth may be the only site involved. Oral KS treatments include surgical removal, radiation therapy, and intralesional chemotherapy. The objective of this case report was to document and evaluate the effectiveness of treating an oral KS lesion in a patient with AIDS using local injections of vinblastine solution (intralesional chemotherapy), aiming to highlight its positive results in a context of complementary treatment of the neoplasm.

References

1. Karamanou M, Antoniou C, Stratigos AJ, Saridaki Z, Androutsos G. The eminent dermatologist Moriz Kaposi (1837-1902) and the first description of idiopathic multiple pigmented sarcoma of the skin. J BUON. 2013 Oct/Dec;18(4):1101-5.

2. Feit H. Sarcoma (Kaposi). Arch Derm Syphilol. 1928;18:611–2 apud Aroua A, Ali RB, Chokri A, Selmi J. Solitary Kaposi’s sarcoma in the oral cavity of an HIV-negative patient: a rare case report. Sch J Med Case Rep. 2017;5(11):713-6.

3. Dittmer DP, Damania B. Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy. J Clin Invest. 2016 Sep;126(9):3165-75.

4. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 1990 Jan;335(8682):123-8.

5. Epstein JB. Treatment of oral Kaposi sarcoma with intralesional vinblastine. Cancer. 1993 Mar;71(5):1722-5.

6. Epstein JB, Lozada-Nur F, McLeod WA, Spinelli J. Oral Kaposi’s sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine. Cancer. 1989 Dec;64(12):2424-30.

7. Fatahzadeh M, Schwartz RA. Oral Kaposi’s sarcoma: a review and update. Int J Dermatol. 2013 Jun;52(6):666-72.

8. McCormick SU. Intralesional vinblastine injections for the treatment of oral Kaposi’s sarcoma: report of 10 patients with 2-year follow-up. J Oral Maxillofac Surg. 1996 May;54(5):583-9.

9. Volberding P, Conant MA, Stricker RB, Lewis BJ. Chemotherapy in advanced Kaposi’s sarcoma. Implications for current cases in homosexual men. Am J Med. 1983 Apr;74(4):652-6.

10. Goncalves PH, Uldrick TS, Yarchoan R. HIV-associated Kaposi sarcoma and related diseases. AIDS. 2017 Sep;31(14):1903-16.

11. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994 Dec;266(5192):1865-9.

12. Gorsky M, Epstein JB. A case series of acquired immunodeficiency syndrome patients with initial neoplastic diagnoses of intraoral Kaposi’s sarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Nov;90(5):612-7.

13. Lebbe C, Blum L, Pellet C, Blanchard G, Verola O, Morel P, et al. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi’s sarcoma. AIDS. 1998 May;12(7):F45-9.

Downloads

Published

2022-06-15

How to Cite

Barbosa-Filho, V. F., & Funari, S. L. (2022). Intralesional vimblastine in oral Kaposi Sarcoma. Infections in Evidence, 1, e202201008. https://doi.org/10.5935/2764-734X.e202201008

Issue

Vol. 1 (2022)

Section

Case Reports

License

Copyright (c) 2022 Infections in Evidence

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Copyright Transfer Agreement assumes that the authors are the legitimate holders of the copyright of the Case Report in question, without infringing any copyright, trademark or patent of others. In this way, they transfer all rights to this manuscript or any revision, version or translation of it to the Journal, including here the exclusivity of its eventual commercialization, provided that in accordance with ethical and moral precepts and relevant Brazilian legislation. All articles in the INFECTIONS IN EVIDENCE Journal are published under the terms of international license 4.0 of the Creative Commons Attribution, which allows users to freely read, download, share and adapt cultural and scientific productions, provided that due credit is given to the original authors and publication.
The Copyright Transfer Agreement also understands that the authors guarantee that the respective Case Report has never been published in another communication vehicle or scientific journal. Papers presented at meetings and/or scientific congresses may be published in the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, provided that they have not been published in whole or in part in their Proceedings or Annals.